BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22863759)

  • 61. The in vitro and in vivo antitumor activity of adenovirus-mediated interleukin-24 expression for laryngocarcinoma.
    Liu J; Sheng W; Xie Y; Shan Y; Miao J; Xiang J; Yang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):29-38. PubMed ID: 20187794
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.
    Nishizaki M; Sasaki J; Fang B; Atkinson EN; Minna JD; Roth JA; Ji L
    Cancer Res; 2004 Aug; 64(16):5745-52. PubMed ID: 15313915
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
    Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
    Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
    J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo.
    Meng MB; Wang HH; Guo WH; Wu ZQ; Zeng XL; Zaorsky NG; Shi HS; Qian D; Niu ZM; Jiang B; Zhao LJ; Yuan ZY; Wang P
    Cancer Lett; 2015 Jan; 356(2 Pt B):985-93. PubMed ID: 25444918
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ING4 enhances paclitaxel's effect on colorectal cancer growth in vitro and in vivo.
    Cao L; Chen S; Zhang C; Chen C; Lu N; Jiang Y; Cai Y; Yin Y; Xu J
    Int J Clin Exp Pathol; 2015; 8(3):2919-27. PubMed ID: 26045800
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts.
    Kawabe S; Munshi A; Zumstein LA; Wilson DR; Roth JA; Meyn RE
    Int J Radiat Biol; 2001 Feb; 77(2):185-94. PubMed ID: 11236925
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.
    Ren T; Shan J; Li M; Qing Y; Qian C; Wang G; Li Q; Lu G; Li C; Peng Y; Luo H; Zhang S; Yang Y; Cheng Y; Wang D; Zhou SF
    Drug Des Devel Ther; 2015; 9():2887-910. PubMed ID: 26089640
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MiR-365 enhances the radiosensitivity of non-small cell lung cancer cells through targeting CDC25A.
    Li H; Jiang M; Cui M; Feng G; Dong J; Li Y; Xiao H; Fan S
    Biochem Biophys Res Commun; 2019 Apr; 512(2):392-398. PubMed ID: 30902389
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma.
    Galal El-Shemi A; Mohammed Ashshi A; Oh E; Jung BK; Basalamah M; Alsaegh A; Yun CO
    Gene Ther; 2018 Jan; 25(1):54-65. PubMed ID: 28925992
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells.
    Kang J; Kim W; Kwon T; Youn H; Kim JS; Youn B
    Oncotarget; 2016 Apr; 7(17):23961-74. PubMed ID: 27004408
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tumor-specific, hypoxia-regulated, WW domain-containing oxidoreductase-expressing adenovirus inhibits human non-small cell lung cancer growth in vivo.
    Zhang P; Ying L; Xu R; Ge S; Mei W; Li F; Dai B; Lu J; Qian G
    Hum Gene Ther; 2010 Jan; 21(1):27-39. PubMed ID: 19737107
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enhancement of cisplatin sensitivity in lung cancer xenografts by liposome-mediated delivery of the plasmid expressing small hairpin RNA targeting Survivin.
    Tian H; Liu S; Zhang J; Zhang S; Cheng L; Li C; Zhang X; Dail L; Fan P; Dai L; Yan N; Wang R; Wei Y; Deng H
    J Biomed Nanotechnol; 2012 Aug; 8(4):633-41. PubMed ID: 22852473
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of ING4 (inhibitor of growth 4) as a modulator of docetaxel sensitivity in human lung adenocarcinoma.
    Wang R; Huang J; Feng B; De W; Chen L
    Mol Med; 2012 Jul; 18(1):874-86. PubMed ID: 22460125
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancer.
    Jung J; Park SJ; Chung HK; Kang HW; Lee SW; Seo MH; Park HJ; Song SY; Jeong SY; Choi EK
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e77-83. PubMed ID: 22795728
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Downregulation of ubiquitin inhibits the proliferation and radioresistance of non-small cell lung cancer cells in vitro and in vivo.
    Tang Y; Geng Y; Luo J; Shen W; Zhu W; Meng C; Li M; Zhou X; Zhang S; Cao J
    Sci Rep; 2015 Mar; 5():9476. PubMed ID: 25820571
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of adenovirus-mediated retinoblastoma 94 in the treatment of human non-small cell lung cancer.
    Liu F; Li Q; Zhang P; Chen F; Cheng Y
    Mol Med Rep; 2015 May; 11(5):3349-53. PubMed ID: 25607217
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aloperine in combination with therapeutic adenoviral vector synergistically suppressed the growth of non-small cell lung cancer.
    Muhammad T; Sakhawat A; Khan AA; Huang H; Khan HR; Huang Y; Wang J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):861-874. PubMed ID: 32088783
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2.
    Zheng M; Morgan-Lappe SE; Yang J; Bockbrader KM; Pamarthy D; Thomas D; Fesik SW; Sun Y
    Cancer Res; 2008 Sep; 68(18):7570-8. PubMed ID: 18794145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.